Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 31, 2020PharmaceuticsOpen Access

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

View Full Paper
Ask AI
Bookmark
Share

Authors

IGIoana Arina GherghescuMDM. Begoña Delgado‐Charro

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gherghescu et al. (2020) studied this question.

synapsesocial.com/papers/6a019a458d267ec217d8b2c8https://doi.org/10.3390/pharmaceutics13010048
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update2020 · 257 citations
  2. 2The Path Towards a Tailored Clinical Biosimilar Development2020 · 68 citations
  3. 3On the Regulatory Approval Pathway of Biosimilar Products2012 · 113 citations
  4. 4The biosimilars journey: current status and ongoing challenges2018 · 18 citations